26th February 2018 – Nottingham, UK – The Discovery Building, Sygnature Discovery’s HQ, has been nominated for the RICS Awards 2018, East Midlands. RICS is the global professional body promoting and enforcing the highest international standards in the valuation, management and development of land, real estate, construction and infrastructure. With eight categories, the RICS Awards are […]
20th February 2018 – Nottingham, UK – A recent publication in the Royal Society of Chemistry’s MedChemComm (MedChemComm, 2018, DOI: 10.1039/C8MD00033F ), highlights the significant contribution made by some of Sygnature Discovery’s medicinal chemists to the design of improved agents in the fight against infections caused by the respiratory syncytial virus (RSV). The project was […]
7th February 2018 – Nottingham, UK – Private equity-backed Sygnature Discovery, the UK’s largest independent provider of integrated drug discovery resource and expertise, is to co-host a symposium in Predictive Toxicology in Discovery DMPK at BioCity Nottingham on 22nd March 2018. This one-day meeting will provide a forum for the exchange of ideas between members of […]
17th January 2018 – Nottingham, UK – A team of Sygnature Discovery chemists has made it to the final of the 5th National RSC/SCI Retrosynthesis Competition in London on 16th March 2018. This prestigious event will showcase the calibre of UK chemists from both industry and academia and provide a platform for them to demonstrate their […]
19th December 2017 – Nottingham, UK – Sygnature Discovery was recently featured, along with BioCity Nottingham, on BBC One – East Midlands Today as prime examples of UK life science success stories. Sygnature’s Founder and CEO, Dr Simon Hirst, was interviewed by the BBC during the filming.